Blood News and Research

RSS

QIAGEN N.V. announces acquisition of ESE GmbH for $19 million

QIAGEN N.V. today announced that it has acquired ESE GmbH, a privately held developer and manufacturer of UV and fluorescence optical measurement devices. ESE is based in Stockach, Germany. The transaction is valued at up to US$19 million in cash.

From QIAGEN Manchester Limited 12 Jan 2010

New hand-held device eliminates technical challenges involved in imaging progressive ROP in infants

Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.

12 Jan 2010

Yoga lowers number of compounds in blood and reduces inflammation

Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

12 Jan 2010

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.

12 Jan 2010

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.

12 Jan 2010

Families should include eye exam as a healthy resolution for New Year

With the start of the New Year, many people are focused on living healthier, more active lifestyles through exercise, proper diet and nutrition, and regular visits to healthcare professionals. One aspect of overall health and wellness that's often overlooked is eye health. It's important for families to include an eye exam as a healthy resolution for the New Year.

12 Jan 2010

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of Clinical Investigation.

12 Jan 2010

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed by hepatitis B and hepatitis C, says a new report from the Institute of Medicine.

12 Jan 2010

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.

12 Jan 2010

Researchers discover new ways for treatment of cancer

Researchers at the Swedish medical university Karolinska Institutet have discovered a new way of blocking the formation of blood vessels and halting the growth of tumours in mice. A substance that exploits this mechanism could be developed into a new treatment for cancer.

12 Jan 2010

Exercise may improve cognitive function

Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition, according to two reports in the January issue of Archives of Neurology, one of the JAMA/Archives journals.

11 Jan 2010

Albertsons launches new online community to provide value-driven choices for healthier living

Albertsons, a SUPERVALU company, today launched a new online community, AlbertsonsWellbeing.com, that will provide users with tools to help them make easy, value-driven choices for healthier living.

11 Jan 2010

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

11 Jan 2010

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.

11 Jan 2010

RMMC selects Allscripts' EHR and Practice Management solutions

Allscripts announced today that Renaissance Medical Management Company (RMMC) has selected the company's Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and administrative processes for a minimum of 51 family practice and internal medicine physicians.

11 Jan 2010

Researchers identify treatment to reduce health problems associated with enzyme defect

An experimental compound repaired a defective alcohol metabolism enzyme that affects an estimated 1 billion people worldwide, according to research supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

10 Jan 2010

Research into "chemical chaperone" may lead to new treatments for heart attacks

Researchers at the Indiana University and Stanford University schools of medicine have determined how a "chemical chaperone" does its job in the body, which could lead to a new class of drugs to help reduce the muscle damage caused by heart attacks.

10 Jan 2010

Study analyses physiological parameters of athletes

The maximum time an athlete is able to continue climbing to exhaustion may be the only determinant of his/her performance. A new European study, led by researchers from the University of Granada, the objective of which is to help trainers and climbers design training programmes for this type of sport, shows this to be the case.

9 Jan 2010

LehmanMillet adds two new accounts: Myriad Genetics and Breathe Technologies

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced the addition of two new accounts: Myriad Genetics and Breathe Technologies.

9 Jan 2010

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

SeraCare Life Sciences, Inc. announced today that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare’s growing customer base in the life sciences industry.

9 Jan 2010

Blood News and Research

QIAGEN N.V. announces acquisition of ESE GmbH for $19 million

New hand-held device eliminates technical challenges involved in imaging progressive ROP in infants

Yoga lowers number of compounds in blood and reduces inflammation

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

Families should include eye exam as a healthy resolution for New Year

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

Researchers discover new ways for treatment of cancer

Exercise may improve cognitive function

Albertsons launches new online community to provide value-driven choices for healthier living

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

RMMC selects Allscripts' EHR and Practice Management solutions

Researchers identify treatment to reduce health problems associated with enzyme defect

Research into "chemical chaperone" may lead to new treatments for heart attacks

Study analyses physiological parameters of athletes

LehmanMillet adds two new accounts: Myriad Genetics and Breathe Technologies

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News